医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
7期
1335-1337,1340
,共4页
半胱氨酸蛋白酶抑制剂/血液%抗原 ,肿瘤相关 ,碳水化合物/分析%骨保护素/生物合成%冠状动脉疾病/代谢
半胱氨痠蛋白酶抑製劑/血液%抗原 ,腫瘤相關 ,碳水化閤物/分析%骨保護素/生物閤成%冠狀動脈疾病/代謝
반광안산단백매억제제/혈액%항원 ,종류상관 ,탄수화합물/분석%골보호소/생물합성%관상동맥질병/대사
Cysteine Proteinase Inhibitors/blood%Antigens,Tumor-Associated,Carbohydrate/Anal-ysis%Osteoprotegerin/Biosynthesis%Coronary Artery Disease/metabolism
【目的】探讨分析冠状动脉粥样硬化性心脏病(CHD)患者血清胱抑素C(CysC)、CA125和骨保护素(OPG)的水平变化及临床意义。【方法】选取本院158例经冠状动脉造影确诊的 CHD 患者作为观察组(CHD组),另选95例健康人作为健康对照组。分别应用免疫比浊法、化学免疫发光法和ELISA法比较不同组别和不同病变支数患者的CysC、CA125、OPG 水平。【结果】与健康对照组比较,CHD组CysC、CA125、OPG水平明显升高( P <0.05或 P <0.01);单支、双支、多支病变组3组血清CysC、CA125、OPG 水平逐渐升高,左室射血分数(LVEF)逐渐下降,且差异均有显著性( P <0.05或 P <0.01);NYHAⅠ级、Ⅱ级、Ⅲ级、Ⅳ级组血清CysC、CA125、OPG水平逐渐升高,LVEF逐渐下降,且差异均有显著性( P<0.05或 P<0.01)。CysC、CA125、OPG 水平均与冠脉病变支数、心功能级别呈正相关( P <0.01),与 LVEF呈负相关( P <0.01)。【结论】联合检测血浆CysC、BMG、OPG 水平不仅能评价心功能受损程度,而且有助于早期发现CHD和有助于冠脉病变严重程度的判断及预后判断。
【目的】探討分析冠狀動脈粥樣硬化性心髒病(CHD)患者血清胱抑素C(CysC)、CA125和骨保護素(OPG)的水平變化及臨床意義。【方法】選取本院158例經冠狀動脈造影確診的 CHD 患者作為觀察組(CHD組),另選95例健康人作為健康對照組。分彆應用免疫比濁法、化學免疫髮光法和ELISA法比較不同組彆和不同病變支數患者的CysC、CA125、OPG 水平。【結果】與健康對照組比較,CHD組CysC、CA125、OPG水平明顯升高( P <0.05或 P <0.01);單支、雙支、多支病變組3組血清CysC、CA125、OPG 水平逐漸升高,左室射血分數(LVEF)逐漸下降,且差異均有顯著性( P <0.05或 P <0.01);NYHAⅠ級、Ⅱ級、Ⅲ級、Ⅳ級組血清CysC、CA125、OPG水平逐漸升高,LVEF逐漸下降,且差異均有顯著性( P<0.05或 P<0.01)。CysC、CA125、OPG 水平均與冠脈病變支數、心功能級彆呈正相關( P <0.01),與 LVEF呈負相關( P <0.01)。【結論】聯閤檢測血漿CysC、BMG、OPG 水平不僅能評價心功能受損程度,而且有助于早期髮現CHD和有助于冠脈病變嚴重程度的判斷及預後判斷。
【목적】탐토분석관상동맥죽양경화성심장병(CHD)환자혈청광억소C(CysC)、CA125화골보호소(OPG)적수평변화급림상의의。【방법】선취본원158례경관상동맥조영학진적 CHD 환자작위관찰조(CHD조),령선95례건강인작위건강대조조。분별응용면역비탁법、화학면역발광법화ELISA법비교불동조별화불동병변지수환자적CysC、CA125、OPG 수평。【결과】여건강대조조비교,CHD조CysC、CA125、OPG수평명현승고( P <0.05혹 P <0.01);단지、쌍지、다지병변조3조혈청CysC、CA125、OPG 수평축점승고,좌실사혈분수(LVEF)축점하강,차차이균유현저성( P <0.05혹 P <0.01);NYHAⅠ급、Ⅱ급、Ⅲ급、Ⅳ급조혈청CysC、CA125、OPG수평축점승고,LVEF축점하강,차차이균유현저성( P<0.05혹 P<0.01)。CysC、CA125、OPG 수평균여관맥병변지수、심공능급별정정상관( P <0.01),여 LVEF정부상관( P <0.01)。【결론】연합검측혈장CysC、BMG、OPG 수평불부능평개심공능수손정도,이차유조우조기발현CHD화유조우관맥병변엄중정도적판단급예후판단。
Objective To explore the changes of serum levels of cystain C (CysC) ,CA125 and osteoprote-gerin(OPG) in patients with coronary heart disease(CHD) and their clinical significance .[Methods]A total of 158 CHD patients in our hospital were chosen as experimental group .Other 95 healthy subjects were chosen as healthy control group .Serum levels of CysC ,CA125 and OPG were compared among different groups and dis-eased vessels by using immunoturbidimetry ,chemiluminescence immunoassay and ELISA .[Results] Com-pared with healthy control group ,serum levels of CysC ,CA125 and OPG in CHD group were obviously in-creased( P <0 .05 or P<0 .01) .Serum levels of CysC ,CA125 and OPG in single ,double and multiple vessel disease groups were gradually increased ,while left ventricular ejection fraction (LVEF) was gradually de-creased ,and there was significant difference( P<0 .05 or P<0 .01) .Serum levels of CysC ,CA125 and OPG level in NYHA Ⅰ ,Ⅱ ,Ⅲ and Ⅳ groups were gradually increased ,but LVEF was gradually decreased ,and there was significant difference( P <0 .05 or P <0 .01) .Serum levels of CysC ,CA125 and OPG were posi-tively correlated with the number of coronary disease vessels and cardiac function classification ( P <0 .01) , and negatively correlated with LVEF ( P <0 .01) .[Conclusion] Serum levels of CysC ,CA125 and OPG can not only evaluate the degree of cardiac function impairment ,but also is helpful for early diagnosis of CHD ,as-sessment of the severity of coronary artery disease and prognosis .